Humanized anti-TLR4 monoclonal antibody ameliorates lipopolysaccharide-related acute kidney injury by inhibiting TLR4/NF-κB signaling

A humanized anti-Toll-like receptor 4 (TLR4) monoclonal antibody (mAb) was previously produced using phage antibody library technology, and it was found that the mAb could effectively ameliorate lipopolysaccharide (LPS)-induced damage in macrophages. The present study investigated the protective eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qiuhua, Wang, Liang, Wu, Mian, Liu, Xiaobin, Zhu, Yushan, Zhu, Jin, Xing, Changying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240183/
https://www.ncbi.nlm.nih.gov/pubmed/34184086
http://dx.doi.org/10.3892/mmr.2021.12245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240183/
https://www.ncbi.nlm.nih.gov/pubmed/34184086
http://dx.doi.org/10.3892/mmr.2021.12245

Ejemplares similares